Revvity is trading 4.01% up now at $131.66, primarily as healthcare-sector strength improves medical-technology sentiment.
- Healthcare is up 1.37%, with strong medical-device earnings supporting the sector.
- No clear company-specific announcement was identified for September 2, 2026.
- Revvity’s latest reported catalyst was its August 4 second-quarter earnings beat and raised guidance; broader equities are modestly higher, but healthcare is the more relevant factor.